BMEA
Biomea Fusion, Inc. · Healthcare
A2A Pharmaceuticals, Inc. sold $408K of Biomea Fusion, Inc.
10% owner
Sold$407,578
$11.76Price
34,658Shares
−1%Stake
What BMEA did after the filing
- The stock from Tue, Jun 28 open, $12.03
- −0.9%
- S&P 500, same days
- +7.6%
Measured over 30 trading days, to the Aug 10 close.
Traded Fri, Jun 24. Filed Tue, Jun 28, 3:51 AM ET, before the open. Returns use the Jun 28 open and the Aug 10 close. Not investment advice.